Advertisement

Psychopharmacology

, Volume 79, Issue 2–3, pp 99–103 | Cite as

Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials

  • M. S. Buchsbaum
  • G. C. Davis
  • D. Naber
  • D. Pickar
Original Investigations

Abstract

The effect of 8 mg IV naloxone on pain appreciation was studied with electric shocks administered to the left forearm of 20 normal volunteers. Pain sensitivity was assessed with a psychophysical task and with evoked potentials (EP) to the pain stimuli which were found sensitive to opiate agonists and antagonists in previous experiments. Naloxone-induced hyperalgesia before and after 20 min of intermittent shock was assessed in a 3-day placebo crossover experiment designed to provide control comparisons of time effects. EP amplitude enhancement with naloxone was significantly greater following 20 min of shocks than preceding them, while pain judgments were not significantly affected. Thus, naloxone increases pain sensitivity, especially after prolonged pain stimulation. This finding is consistent with endorphin mediation of stress-induced analgesia and raises the question of whether this type of response decrement over time is related to the phenomena of habituation.

Key words

Stress Naloxone Somatosensory Evoked potentials 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akil H, Watson SJ (1980) The role of endogenous opiates in pain control. In: Kosterlitz HW, Terenius LY (eds) Pain and society. Verlag Chemi, Weinheim, p 201–222Google Scholar
  2. Akil H, Watson SJ, Berger PA, Barchas JD (1978) Stress-induced analgesia in humans: Endogenous, opioids and naloxone-reversible depression of pain reflexes. In: Costa E, Trabucchi M (eds) Advances in biochemical psychopharmacology. Raven, New York, pp 125–139Google Scholar
  3. Amir S, Amit Z (1978) Endogenous opioid ligands may mediate stress-induced changes in the affective properties of pain-related behavior in rats. Life Sci 23:1143–1152Google Scholar
  4. Beecher HK (1957) The measurement of pain. Pharmacol Rev 9:59–209Google Scholar
  5. Beluzzi JD, Grant N, Garsky V, Sarantakis D, Wise CD, Stein L (1976) Analgesia induced in vivo by central administration of enkephalin in rat. Nature 260:625–626Google Scholar
  6. Bengt HS, Eriksson MB (1979) The influence of naloxone on analgesia produced by peripheral conditioning stimulation. Brain Res 173:295–301Google Scholar
  7. Buchsbaum MS, Davis GC, Bunney Jr WE (1977a) Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270:620–622Google Scholar
  8. Buchsbaum MS, Davis GC, Coppola R, Naber D (1981a) Opiate pharmacology and individual differences. I. Psychophysical pain measurements. Pain 10:357–366Google Scholar
  9. Buchsbaum MS, Davis GC, Coppola R, Naber D (1981b) Opiate pharmacology and individual differences. II. Somatosensory evoked potentials. Pain 10:367–377Google Scholar
  10. Buchsbaum MS, Davis GC, Goodwin FK, Murphy DL, Post RM (1980) Psychophysical pain judgments and somatosensory evoked potentials in patients with affective illness and normal adults. In: Perris C, Von Knorring L, Kemali D (eds) Recent advances in biological psychiatry. S. Karger AG, Basel, Switzerland, pp 63–72Google Scholar
  11. Buchsbaum MS, Post RM, Bunney Jr WE (1977b) Average evoked responses in a rapidly cycling manic-depressive patient. Biol Psychiatry 12:83–99Google Scholar
  12. Buscher HH, Hill RC, Romer D, Cardinaux F, Closse A, Hauser D, Pless J (1976) Evidence for analgesic activity of enkephalin in the mouse. Nature 261:423–425Google Scholar
  13. Davis GC, Buchsbaum MS, Bunney Jr WE (1978) Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials. Life Sci 23:1449–1460Google Scholar
  14. Davis GC, Buchsbaum MS, Naber D, Pickar D, Post R, van Kammen D, Bunney Jr WE (1982) Altered pain perception and CSF endorphins in psychiatric illness. NY Acad Sci (in press)Google Scholar
  15. Dubois M, Pickar D, Cohen MR, Roth YF, MacNamara T, Bunney Jr WE (1981) Surgical stress in humans is accompanied by an increase in plasma beta-endorphin immunoreactivity. Life Sci 29:1249–1254Google Scholar
  16. El-Sobky A, Dostrovsky JO, Wall PD (1976) Lack of effect of naloxone on pain perception in humans. Nature 263:783–784Google Scholar
  17. Frederickson RC, Burgis V, Edwards JD (1977) Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science 19:756–758Google Scholar
  18. Goldstein A, Grevert P (1978) Placebo analgesia, endorphins, and naloxone. Lancet II:1385Google Scholar
  19. Grevert P, Goldstein A (1977) Effect of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proc Natl Acad Sci USA 74:1291–1294Google Scholar
  20. Grau JW, Hyson RL, Maier S, Madden J, Barchas JD (1981) Long-term stress-induced analgesia and activation of the opiate system. Science 213:1409–1414Google Scholar
  21. Hosobuchi Y, Adams JE, Linchitz R (1977) Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science 197:183–186Google Scholar
  22. Lavine R, Buchsbaum MS, Poncy M (1976) Auditory analgesia: Somatosensory evoked response and subjective pain rating. Psychophysiology 13:140–148Google Scholar
  23. Levine JD, Fields HL (1978) Mechanism of placebo analgesia. Lancet II:1304–1305Google Scholar
  24. Lewis JW, Liebeskind JC (1980) Opioid and nonopioid mechanisms of stress analgesia. Science 208:623–625Google Scholar
  25. Lord JAH, Waterfield AA, Hughes J, Kosterlitz H (1977) Endogenous opioid peptides: Multiple agonists and receptors. Nature 267:495–499Google Scholar
  26. Naber D, Davis GC, Buchsbaum MS, Pert CB (1980) Effects of morphine and naloxone on pain sensitivity and somatosensory evoked potentials: Relationship to beta-endorphin plasma level. Arzneim Forsch 30:1236Google Scholar
  27. Ohman A, Lader M (1972) Selective attention and habituation of the auditory average evoked response in humans. Physiol Behav 8:79–85Google Scholar
  28. Procacci P, Della Corte M, Zoppi M, Romano S, Maresca M, Voegelin MR (1972) Pain threshold measurements in man. In: Bonica JJ, Procassi P, Pagni CA (eds) Recent advances on pain. Thomas, Springfield, pp 105–147Google Scholar
  29. Rhodewald P, Derendorf H, Drehsen G, Elger CE, Knoll O (1982) Changes in cortical evoked potentials as correlates of the efficacy of weak analgesics. Pain 12:329–341Google Scholar
  30. Satoh M, Kawajiri S, Yamamoto M, Makino H, Takagi H (1979) Reversal by naloxone of adaptation of rats to noxious stimuli. Life Sci 24:685–690Google Scholar
  31. Sitaram N, Buchsbaum MS, Gillin JC (1977) Physostigmine analgesia and somatosensory evoked responses in man. Eur J Pharmacol 42:285–290Google Scholar
  32. Thompson RF, Spencer WA (1966) Habituation: A model phenomenon for the study of neuronal substrates of behavior. Psychol Rev 73:16–43Google Scholar
  33. Volavka J, James B, Reker D, Pollock V, Cho D (1979) Electroencephalographic and other effects of naloxone in normal man. Life Sci 25:1267–1272Google Scholar
  34. Willer JC, Dehen H, Cambier J (1981) Stress-induced analgesia in humans: Endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212:689–691Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • M. S. Buchsbaum
    • 1
  • G. C. Davis
    • 2
  • D. Naber
    • 3
  • D. Pickar
    • 1
  1. 1.Biological Psychiatry BranchNIMHBethesdaUSA
  2. 2.Psychiatry Research ProgramCleveland VAMC and Case Western Reserve UniversityClevelandUSA
  3. 3.Psychiatrische Klinik der Universität MünchenFederal Republic of Germany

Personalised recommendations